| Literature DB >> 26468118 |
Teresa W Wang1, Roel C H Vermeulen2, Wei Hu3, Gang Liu4, Xiaohui Xiao4, Yuriy Alekseyev5, Jun Xu6, Boris Reiss7, Katrina Steiling1, George S Downward2, Debra T Silverman3, Fusheng Wei8, Guoping Wu8, Jihua Li9, Marc E Lenburg10, Nathaniel Rothman3, Avrum Spira11, Qing Lan3.
Abstract
In China's rural counties of Xuanwei and Fuyuan, lung cancer rates are among the highest in the world. While the elevated disease risk in this population has been linked to the usage of smoky (bituminous) coal as compared to smokeless (anthracite) coal, the underlying molecular changes associated with this exposure remains unclear. To understand the physiologic effects of smoky coal exposure, we analyzed the genome-wide gene-expression profiles in buccal epithelial cells collected from healthy, non-smoking female residents of Xuanwei and Fuyuan who burn smoky (n = 26) and smokeless (n = 9) coal. Gene-expression was profiled via microarrays, and changes associated with coal type were correlated to household levels of fine particulate matter (PM2.5) and polycyclic aromatic hydrocarbons (PAHs). Expression levels of 282 genes were altered with smoky versus smokeless coal exposure (P < 0.005), including the 2-fold increase of proinflammatory IL8 and decrease of proapoptotic CASP3. This signature was more correlated with carcinogenic PAHs (e.g. Benzo[a]pyrene; r = 0.41) than with non-carcinogenic PAHs (e.g. Fluorene; r = 0.08) or PM2.5 (r = 0.05). Genes altered with smoky coal exposure were concordantly enriched with tobacco exposure in previously profiled buccal biopsies of smokers and non-smokers (GSEA, q < 0.05). This is the first study to identify a signature of buccal epithelial gene-expression that is associated with smoky coal exposure, which in part is similar to the molecular response to tobacco smoke, thereby lending biologic plausibility to prior epidemiological studies that have linked this exposure to lung cancer risk. Published by Oxford University Press 2015.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26468118 PMCID: PMC4675833 DOI: 10.1093/carcin/bgv150
Source DB: PubMed Journal: Carcinogenesis ISSN: 0143-3334 Impact factor: 4.944